Efficacy of abatacept following wash-out of anti-TNF therapy in rheumatoid arthritis patients in the ATTAIN (Abatacept Trial in Treatment of Anti-TNF INadequate Responders) trial: Current versus prior discontinuation. 69th Annual Scientific Meeting of the American-College-of-Rheumatology/40th Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals Genovese, M., Schiff, M., Luggen, M., Aranda, R., Becker, J. C., White, A., Dougados, M. WILEY-BLACKWELL. 2005: S560–S561

View details for Web of Science ID 000232207803035